Trial Profile
Study of AV4025 in combination with other drugs in HCV-infected patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2016
Price :
$35
*
At a glance
- Drugs AV 4025 (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 Apr 2016 New trial record